M.D. Anderson Cancer Center: all 3,044 studies

Page 18 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA TrialWithdrawnNCT04756505Phase 1
• Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate CancerTerminatedNCT04754425Phase 2
• Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal StudyActive, not recruitingNCT04754412Not applicable
• Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid LeukemiaActive, not recruitingNCT04746235Phase 2
• Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis SyndromeCompletedNCT04745910Phase 4
• Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health OutcomesActive, not recruitingNCT04743466
• Viral Specific T Cell Therapy for COVID-19 Related PneumoniaCompletedNCT04742595Early Phase 1
• Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaActive, not recruitingNCT04734990Phase 1/2
• SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIALTerminatedNCT04729725Phase 1
• Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-respondersActive, not recruitingNCT04729322Phase 2
• Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO TrialActive, not recruitingNCT04728230Phase 1/2
• Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver CancerActive, not recruitingNCT04721132Phase 2
• Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic CholangiocarcinomaActive, not recruitingNCT04708067Phase 1
• Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine CarcinomasActive, not recruitingNCT04701307Phase 2
• Acceptability of 3D Printed Breast Models as Surgical Decision Aids for Breast Cancer TreatmentCompletedNCT04693364
• Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell TransplantActive, not recruitingNCT04678427Not applicable
• Infertility Survey Among Reproductive Age Women With Gynecological and Breast CancerActive, not recruitingNCT04678414
• Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid CancerActive, not recruitingNCT04675710Phase 2
• Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic SarcomaActive, not recruitingNCT04668300Phase 2
• Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaActive, not recruitingNCT04655755Phase 1/2
• Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID StudyCompletedNCT04652505
• Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical TrialsActive, not recruitingNCT04650178
• Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving ImmunotherapyActive, not recruitingNCT04645680Phase 2
• Parent and Family Oriented Support Interventions for the Facilitation of Weight Loss in African American FamiliesActive, not recruitingNCT04644224Not applicable
• Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer SurvivorsActive, not recruitingNCT04634617
• Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical CancerActive, not recruitingNCT04622670Not applicable
• LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal CancerActive, not recruitingNCT04616183Phase 1/2
• Project Self in Improving Cervical Cancer Screening Rates in Hispanic and African American WomenCompletedNCT04614155Not applicable
• Yoga Program for Improving the Quality of Life in Couples Coping With CancerActive, not recruitingNCT04607590Not applicable
• Prediction of Recurrence Among Low Risk Endometrial Cancer PatientsActive, not recruitingNCT04604613
• SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 TrialActive, not recruitingNCT04599140Phase 1/2
• Electroencephalographic Changes Under General Anesthesia in Patients With Gynecologic Cancers With and Without History of ChemotherapyCompletedNCT04593550
• Financial Toxicity in Cancer PatientsActive, not recruitingNCT04592250
• Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate CancerActive, not recruitingNCT04592237Phase 2
• Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART StudyWithdrawnNCT04585932Phase 2
• MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK TrialWithdrawnNCT04580836Phase 2
• A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV TrialActive, not recruitingNCT04580771Phase 2
• Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical PneumoniaActive, not recruitingNCT04565665Phase 1/2
• Safety of MRI Compatible Hardware for MRI-based Image Guidance During Spine SurgeryTerminatedNCT04563806Early Phase 1
• Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing SurgeryActive, not recruitingNCT04560712Not applicable
• Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral NeuropathyActive, not recruitingNCT04560673Phase 2
• Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home ProgramWithdrawnNCT04557709
• Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent GlioblastomaActive, not recruitingNCT04555577Phase 1
• Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade GliomaActive, not recruitingNCT04553757
• Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma SurgeonsWithdrawnNCT04553744
• Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaTerminatedNCT04550442Phase 1/2
• Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root GangliaWithdrawnNCT04533919
• Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory LeukemiaTerminatedNCT04526795Phase 1
• Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric AdenocarcinomaActive, not recruitingNCT04523818Phase 1
• Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal CancerCompletedNCT04522336Phase 1
• Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
• Elotuzumab for the Treatment of JAK2-Mutated MyelofibrosisActive, not recruitingNCT04517851Phase 2
• Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic CancersActive, not recruitingNCT04516135Phase 2
• Bone Loss in Melanoma Survivors Receiving ImmunotherapyTerminatedNCT04516122
• Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain MetastasisActive, not recruitingNCT04516070Phase 2
• Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19)Status unknownNCT04513990Not applicable
• NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung CancerActive, not recruitingNCT04505267Phase 1
• Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic LeukemiaActive, not recruitingNCT04505254Phase 2
• Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 PandemicActive, not recruitingNCT04500600
• Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL MutationsActive, not recruitingNCT04493138Phase 1/2
• Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AMLWithdrawnNCT04493099Phase 1/2
• Perioperative Care in the Cancer Patient -1, ARCA-1 StudyCompletedNCT04491409
• NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic CancerActive, not recruitingNCT04484909Phase 1
• Assessment of What Patients and Healthcare Providers ValueCompletedNCT04483349
• New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc StudyWithdrawnNCT04481204Phase 2
• Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung CancerCompletedNCT04479306Phase 1
• Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive, not recruitingNCT04458610Phase 2
• Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and SurvivorsActive, not recruitingNCT04447222
• Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyActive, not recruitingNCT04430725
• Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or MelanomaActive, not recruitingNCT04407247Phase 1/2
• DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell CancersActive, not recruitingNCT04388852Phase 1
• Ventilatory Strategy for the Prevention of Atelectasis During Bronchoscopy Under General Anesthesia, VESPA TrialCompletedNCT04311723Not applicable
• Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin ChemotherapyActive, not recruitingNCT04310826Not applicable
• Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer PainActive, not recruitingNCT04296305Phase 4
• Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer ExamWithdrawnNCT04286386
• Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With LymphomaActive, not recruitingNCT04270266Not applicable
• Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic CancerActive, not recruitingNCT04266886Not applicable
• Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their RelativesCompletedNCT04257045
• Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell TransplantTerminatedNCT04239989Phase 1
• Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic PainCompletedNCT04239976Not applicable
• Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African AmericansActive, not recruitingNCT04236882Not applicable
• Paclitaxel for the Treatment of Gastric or Gastroesophageal CancerActive, not recruitingNCT04220827Phase 1
• Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin LymphomaWithdrawnNCT04220008Phase 2
• FDG PET-MRI for the Diagnosis of Spinal Cord LesionsCompletedNCT04219969Not applicable
• PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical CancerActive, not recruitingNCT04219904Early Phase 1
• Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African AmericansActive, not recruitingNCT04215029Not applicable
• Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)Active, not recruitingNCT04200534Early Phase 1
• Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging CliniciansActive, not recruitingNCT04196972Not applicable
• Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their PartnersActive, not recruitingNCT04189770
• Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell LymphomaActive, not recruitingNCT04189757Phase 2
• Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer PatientsActive, not recruitingNCT04188418Phase 3
• Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous LeukemiaCompletedNCT04188405Phase 2
• Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care SettingsCompletedNCT04186884
• Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation TherapyActive, not recruitingNCT04186832Not applicable
• Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph NodesCompletedNCT04185337Early Phase 1
• Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid CancerActive, not recruitingNCT04171622Phase 2
• Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic SyndromeTerminatedNCT04160052Phase 1/2
• Cryoablation for the Treatment of Metastatic CancerActive, not recruitingNCT04150939Not applicable
• Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral NeuropathyWithdrawnNCT04135326Early Phase 1
• Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain LesionsCompletedNCT04132843Not applicable

← M.D. Anderson Cancer Center overview and focus areas